Laura Carpin Kennedy

机构：Vanderbilt University Medical Center · ORCID：0000-0001-8958-7909

发表论文 84 篇 · 总被引 1814 次 · h-index 13

代表论文

• Adverse events in patients treated with neoadjuvant chemo/immunotherapy for triple negative breast cancer: results from seven academic medical centers (2025 · Breast Cancer Research and Treatment · 被引 11)
• Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort (2024 · Clinical Cancer Research · 被引 8)
• A phase I trial of intratumoral STX-001: A novel self-replicating mRNA expressing IL-12 alone or with pembrolizumab in advanced solid tumors. (2024 · Journal of Clinical Oncology · 被引 7)
• Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial (2025 · Annals of Surgical Oncology · 被引 5)
• A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic estrogen receptor positive breast cancer (2025 · npj Breast Cancer · 被引 3)
• Involved Neck Only Versus Mucosal Radiation Therapy for Head and Neck Squamous Cell Cancer of Unknown Primary (HNSCCUP): A National Retrospective Multicenter Cohort Study (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 2)